WallStreetZenWallStreetZen

NASDAQ: GTBP
Gt Biopharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their GTBP stock forecasts and price targets.

Forecast return on equity

Is GTBP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is GTBP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GTBP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GTBP$3.80N/AN/A
HOTH$1.18$5.50+366.10%Strong Buy
KA$0.49$8.00+1,546.09%Buy
OGEN$1.13N/AN/A
SONN$1.77$18.50+945.20%Strong Buy

Gt Biopharma Stock Forecast FAQ

What is GTBP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GTBP) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Gt Biopharma stock.

What is GTBP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GTBP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.